The product information that follows concerns a prescription-only medicine and is intended for registered healthcare professionals in Pakistan. Please confirm to continue.
Tigecycline 50 mg for complicated infections, including those caused by multidrug-resistant organisms.
Tigradox® is tigecycline 50 mg, a lyophilised powder for intravenous infusion. A glycylcycline of the tetracycline class, it offers one agent across polymicrobial critical-care infection.
Activity across resistant Gram-positive, Gram-negative, anaerobic and atypical pathogens.
No adjustment required in renal impairment or dialysis.
100 mg loading dose, then 50 mg every 12 hours. No therapeutic drug monitoring.
Complicated intra-abdominal infections and complicated skin and soft tissue infections, including those caused by multidrug-resistant organisms, and community-acquired pneumonia, as set out in the approved prescribing information.
Tigecycline 50 mg, lyophilised powder for injection. Drug class: glycylcycline (tetracycline class).
Loading dose 100 mg IV over 30–60 minutes, then 50 mg every 12 hours. Severe hepatic impairment: 25 mg every 12 hours after the loading dose. No adjustment in renal impairment or dialysis.
Store at 20–25°C; excursions permitted to 15–30°C. Once mixed in an IV bag with 0.9% sodium chloride or 5% dextrose, may be refrigerated and used within 48 hours.
See the important safety information below and the approved prescribing information.
| Brand | Tigradox® |
|---|---|
| Generic | Tigecycline |
| Strength | 50 mg per vial |
| Dosage form | Lyophilised powder for injection / infusion |
| Pack | Single vial |
| Therapeutic area | Anti-infectives · critical care |
| Prescription status | Prescription-only medicine |
| Manufacturer | Biogen Life Sciences, Rawalpindi |
| Manufacturing licence no. | 000911 |
| DRAP registration no. | 131534 |
| Marketed by | Salventis Pharma SMC (Pvt.) Ltd., Islamabad |
